Ann Marie O'Neill/Linkedin
Aug 22, 2025, 14:36
Join the Thrombosis UK Survey on Severe Thrombophilia: Improve Diagnosis and Treatment Worldwide
Ann Marie O’Neill, a member of The World Thrombosis Day Steering Committee, shared a post on Linkedin:
“Help shape the future of thrombophilia care
Patients living with severe thrombophilia are invited to participate in an important research opportunity.
This research initiative aims to gather critical insights directly from patients to inform global efforts in improving diagnosis, treatment protocols and overall patient outcomes.
The survey is for patients living with severe thrombophilia, including:
- Antithrombin Deficiency
- Protein C Deficiency
- Protein S Deficiency
- Homozygous Factor V Leiden
- Combinations such as Factor V Leiden and Prothrombin 20210.”

Patients living with severe thrombophilia are invited to participate in an important research opportunity developed by Thrombosis UK.
For the survey, check here.
Find similar posts on Hemostasis Today.
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism
-
Aug 31, 2026, 15:41Adrien Jossart: Acute Thrombotic Storm Following Single Heparin Bolus
-
Aug 31, 2026, 15:36Bernhard Gerber: Myocardial Platelet Activation Linked to Microvascular Obstruction After STEMI
-
Aug 31, 2026, 15:34Higher Fibrinogen γ′ Linked to Increased Risk of Recurrent Arterial Thrombosis – Journal of Thrombosis and Haemostasis
-
Aug 31, 2026, 15:21Ney Carter Borges: Anticoagulation Versus Antiplatelet Therapy After TAVI ESC 26